Safety and Efficacy Study of TH-302 CNS Penetration in Recurrent High Grade Astrocytoma Following Bevacizumab

Clinical Trial ID NCT01403610

PubWeight™ 2.07‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01403610

Top papers

Rank Title Journal Year PubWeight™‹?›
1 γ-H2AX and other histone post-translational modifications in the clinic. Biochim Biophys Acta 2012 1.07
2 Metabolic and hypoxic adaptation to anti-angiogenic therapy: a target for induced essentiality. EMBO Mol Med 2015 1.07
Next 100